Reasons for pretreatment attrition and dropout from methylphenidate in adults with attention-deficit/hyperactivity disorder: the role of comorbidities

J Clin Psychopharmacol. 2009 Dec;29(6):614-6. doi: 10.1097/JCP.0b013e3181c00b1e.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Attention Deficit Disorder with Hyperactivity / epidemiology*
  • Attention Deficit Disorder with Hyperactivity / psychology
  • Comorbidity
  • Humans
  • Methylphenidate / therapeutic use*
  • Patient Compliance* / psychology
  • Patient Dropouts* / psychology

Substances

  • Methylphenidate